Limits of Legal AI in Healthcare
Healthcare company associate GC on where legal AI products break down
This exchange points to the real limit of legal AI in regulated healthcare, the hard part is not reading clauses, it is recognizing when an arrangement that looks ordinary on paper is actually a disguised transfer of value. The interviewee draws a line between document level pattern matching and lived deal judgment, especially in AKS, Stark, FDA, and privacy sensitive work where the business reality matters as much as the wording.
-
In this workflow, failure happens in two concrete ways, the model misses the issue entirely, or it reads the words but not the commercial setup behind them. That matters in healthcare because compliance risk often sits in who gets paid, how referrals move, and what practical behavior the contract will induce, not just in whether a clause matches precedent.
-
This fits a broader pattern in legal AI. Large firms report that general platforms like Harvey and Legora work best for first drafts, summaries, and research, while practice specific tools do better when they ask the right follow up questions and carry narrow domain context. General tools are useful on the happy path, but they flatten edge cases.
-
It also explains why in house buyers keep asking for AI inside a contract workflow, not as a standalone chat tool. The desired product is one that ingests a company’s own agreements, flags where a third party paper departs from internal positions, and routes humans to the risky spots. That is a review assist product, not an autonomous compliance lawyer.
The category is heading toward a split. Horizontal legal copilots will keep winning drafting, summarization, and research, while the highest value compliance work will move to narrower products embedded in contract and review systems, trained around specific workflows and still designed to escalate judgment calls to experienced humans.